These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 28778369)
1. Discovery of new leads against Mycobacterium tuberculosis using scaffold hopping and shape based similarity. Wavhale RD; Martis EAF; Ambre PK; Wan B; Franzblau SG; Iyer KR; Raikuvar K; Macegoniuk K; Berlicki Ł; Nandan SR; Coutinho EC Bioorg Med Chem; 2017 Sep; 25(17):4835-4844. PubMed ID: 28778369 [TBL] [Abstract][Full Text] [Related]
2. Antimycobacterial agents. Novel diarylpyrrole derivatives of BM212 endowed with high activity toward Mycobacterium tuberculosis and low cytotoxicity. Biava M; Porretta GC; Poce G; Supino S; Deidda D; Pompei R; Molicotti P; Manetti F; Botta M J Med Chem; 2006 Aug; 49(16):4946-52. PubMed ID: 16884306 [TBL] [Abstract][Full Text] [Related]
3. New derivatives of BM212: A class of antimycobacterial compounds based on the pyrrole ring as a scaffold. Biava M; Porretta GC; Manetti F Mini Rev Med Chem; 2007 Jan; 7(1):65-78. PubMed ID: 17266639 [TBL] [Abstract][Full Text] [Related]
4. Antimycobacterial compounds. New pyrrole derivatives of BM212. Biava M; Porretta GC; Deidda D; Pompei R; Tafi A; Manetti F Bioorg Med Chem; 2004 Mar; 12(6):1453-8. PubMed ID: 15018918 [TBL] [Abstract][Full Text] [Related]
5. New pyrrole derivatives as antimycobacterial agents analogs of BM212. Biava M; Fioravanti R; Porretta GC; Deidda D; Maullu C; Pompei R Bioorg Med Chem Lett; 1999 Oct; 9(20):2983-8. PubMed ID: 10571160 [TBL] [Abstract][Full Text] [Related]
6. Bactericidal activities of the pyrrole derivative BM212 against multidrug-resistant and intramacrophagic Mycobacterium tuberculosis strains. Deidda D; Lampis G; Fioravanti R; Biava M; Porretta GC; Zanetti S; Pompei R Antimicrob Agents Chemother; 1998 Nov; 42(11):3035-7. PubMed ID: 9797251 [TBL] [Abstract][Full Text] [Related]
8. 1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings. Biava M; Porretta GC; Poce G; De Logu A; Saddi M; Meleddu R; Manetti F; De Rossi E; Botta M J Med Chem; 2008 Jun; 51(12):3644-8. PubMed ID: 18494459 [TBL] [Abstract][Full Text] [Related]
9. Design and Synthesis of 1-((1,5-Bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methylpiperazine (BM212) and N-Adamantan-2-yl-N'-((E)-3,7-dimethylocta-2,6-dienyl)ethane-1,2-diamine (SQ109) Pyrrole Hybrid Derivatives: Discovery of Potent Antitubercular Agents Effective against Multidrug-Resistant Mycobacteria. Bhakta S; Scalacci N; Maitra A; Brown AK; Dasugari S; Evangelopoulos D; McHugh TD; Mortazavi PN; Twist A; Petricci E; Manetti F; Castagnolo D J Med Chem; 2016 Mar; 59(6):2780-93. PubMed ID: 26907951 [TBL] [Abstract][Full Text] [Related]
10. Repurposing of a drug scaffold: Identification of novel sila analogues of rimonabant as potent antitubercular agents. Ramesh R; Shingare RD; Kumar V; Anand A; B S; Veeraraghavan S; Viswanadha S; Ummanni R; Gokhale R; Srinivasa Reddy D Eur J Med Chem; 2016 Oct; 122():723-730. PubMed ID: 27476117 [TBL] [Abstract][Full Text] [Related]
11. Antimycobacterial compounds. Optimization of the BM 212 structure, the lead compound for a new pyrrole derivative class. Biava M; Porretta GC; Poce G; Deidda D; Pompei R; Tafi A; Manetti F Bioorg Med Chem; 2005 Feb; 13(4):1221-30. PubMed ID: 15670931 [TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel carbazole tethered pyrrole derivatives as potent inhibitors of Mycobacterium tuberculosis. Surineni G; Yogeeswari P; Sriram D; Kantevari S Bioorg Med Chem Lett; 2015 Feb; 25(3):485-91. PubMed ID: 25559743 [TBL] [Abstract][Full Text] [Related]
13. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors. Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of antimycobacterial activity of new benzimidazole aminoesters. Yoon YK; Ali MA; Wei AC; Choon TS; Ismail R Eur J Med Chem; 2015 Mar; 93():614-24. PubMed ID: 24996257 [TBL] [Abstract][Full Text] [Related]
15. In vivo potent BM635 analogue with improved drug-like properties. Poce G; Cocozza M; Alfonso S; Consalvi S; Venditti G; Fernandez-Menendez R; Bates RH; Barros Aguirre D; Ballell L; De Logu A; Vistoli G; Biava M Eur J Med Chem; 2018 Feb; 145():539-550. PubMed ID: 29335214 [TBL] [Abstract][Full Text] [Related]
16. 1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation. Biava M; Porretta GC; Poce G; De Logu A; Meleddu R; De Rossi E; Manetti F; Botta M Eur J Med Chem; 2009 Nov; 44(11):4734-8. PubMed ID: 19595488 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles. Shingalapur RV; Hosamani KM; Keri RS Eur J Med Chem; 2009 Oct; 44(10):4244-8. PubMed ID: 19540630 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives. Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D; Peethambar SK; Achur R; Kumar HS Eur J Med Chem; 2015 May; 95():49-63. PubMed ID: 25794789 [TBL] [Abstract][Full Text] [Related]
19. Benzimidazole-based compounds kill Mycobacterium tuberculosis. Gong Y; Somersan Karakaya S; Guo X; Zheng P; Gold B; Ma Y; Little D; Roberts J; Warrier T; Jiang X; Pingle M; Nathan CF; Liu G Eur J Med Chem; 2014 Mar; 75():336-53. PubMed ID: 24556148 [TBL] [Abstract][Full Text] [Related]
20. Tapping into the antitubercular potential of 2,5-dimethylpyrroles: A structure-activity relationship interrogation. Semenya D; Touitou M; Masci D; Ribeiro CM; Pavan FR; Dos Santos Fernandes GF; Gianibbi B; Manetti F; Castagnolo D Eur J Med Chem; 2022 Jul; 237():114404. PubMed ID: 35486992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]